Bladder cancer combo trial pulled before it even started
Disease control
Terminated
This study was designed to test a combination of three drugs (N-803, pembrolizumab, and enfortumab vedotin) in people with advanced bladder cancer who had not received prior treatment. The goal was to see if the combination was safe and helped control the cancer. However, the tri…
Phase: PHASE1 • Sponsor: Vadim S Koshkin • Aim: Disease control
Last updated May 13, 2026 16:01 UTC